JP5801994B2 - バイオゲル - Google Patents

バイオゲル Download PDF

Info

Publication number
JP5801994B2
JP5801994B2 JP2009537703A JP2009537703A JP5801994B2 JP 5801994 B2 JP5801994 B2 JP 5801994B2 JP 2009537703 A JP2009537703 A JP 2009537703A JP 2009537703 A JP2009537703 A JP 2009537703A JP 5801994 B2 JP5801994 B2 JP 5801994B2
Authority
JP
Japan
Prior art keywords
fibrinogen
carrier
biogel
fibrinogen binding
molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2009537703A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010510818A (ja
JP2010510818A5 (OSRAM
Inventor
グレッグ ウォーカー，
グレッグ ウォーカー，
Original Assignee
ヘモスタティクス リミテッド
ヘモスタティクス リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ヘモスタティクス リミテッド, ヘモスタティクス リミテッド filed Critical ヘモスタティクス リミテッド
Publication of JP2010510818A publication Critical patent/JP2010510818A/ja
Publication of JP2010510818A5 publication Critical patent/JP2010510818A5/ja
Application granted granted Critical
Publication of JP5801994B2 publication Critical patent/JP5801994B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0031—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/06—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Surgical Instruments (AREA)
JP2009537703A 2006-11-27 2007-11-27 バイオゲル Active JP5801994B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0623607.9A GB0623607D0 (en) 2006-11-27 2006-11-27 Tissue adhesive
GB0623607.9 2006-11-27
PCT/GB2007/004538 WO2008065388A2 (en) 2006-11-27 2007-11-27 Biogel

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013130066A Division JP2013188550A (ja) 2006-11-27 2013-06-20 バイオゲル

Publications (3)

Publication Number Publication Date
JP2010510818A JP2010510818A (ja) 2010-04-08
JP2010510818A5 JP2010510818A5 (OSRAM) 2011-01-20
JP5801994B2 true JP5801994B2 (ja) 2015-10-28

Family

ID=37636565

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009537703A Active JP5801994B2 (ja) 2006-11-27 2007-11-27 バイオゲル
JP2013130066A Pending JP2013188550A (ja) 2006-11-27 2013-06-20 バイオゲル

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013130066A Pending JP2013188550A (ja) 2006-11-27 2013-06-20 バイオゲル

Country Status (13)

Country Link
US (2) US9339584B2 (OSRAM)
EP (2) EP2099505B1 (OSRAM)
JP (2) JP5801994B2 (OSRAM)
CN (1) CN101687061B (OSRAM)
AU (1) AU2007327100B2 (OSRAM)
CA (1) CA2669738C (OSRAM)
DK (1) DK2099505T3 (OSRAM)
ES (2) ES2896053T3 (OSRAM)
GB (1) GB0623607D0 (OSRAM)
IL (1) IL198699A (OSRAM)
PL (1) PL2099505T3 (OSRAM)
RU (1) RU2503464C2 (OSRAM)
WO (1) WO2008065388A2 (OSRAM)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8623336B2 (en) 2008-12-15 2014-01-07 Council Of Scientific & Industrial Research Transparent xyloglucan/chitosan gel and a process for the preparation thereof
AU2011260258B2 (en) * 2010-06-01 2015-07-09 Baxter Healthcare S.A. Process for making dry and stable hemostatic compositions
GB201101740D0 (en) 2011-02-01 2011-03-16 Haemostatix Ltd Therapeutic agents with improved fibrinogen binding
GB201201751D0 (en) * 2012-02-01 2012-03-14 Haemostatix Ltd Haemostatic wound dressing
MX356867B (es) * 2012-12-07 2018-06-18 Baxter Healthcare Sa Espuma hemostatica.
IL230151A0 (en) * 2013-12-24 2014-09-30 Omrix Biopharmaceuticals Ltd One-component fibrin glue containing a polymerization inhibitor
GB201400292D0 (en) 2014-01-08 2014-02-26 Haemostatix Ltd Peptide dendrimers and agents
IL231792A0 (en) 2014-03-27 2014-08-31 Omrix Biopharmaceuticals Ltd Device and method for the preparation and administration of one-component fibrin glue
EA028039B1 (ru) * 2014-09-05 2017-09-29 Частное Учреждение Лаборатория Биотехнологических Исследований "3Д Биопринтинг Солюшенс" Устройство и способы печати биологических тканей и органов
IL235751A0 (en) * 2014-11-18 2015-02-26 Omrix Biopharmaceuticals Ltd An addition to the spray dryer
GB201508024D0 (en) 2015-05-11 2015-06-24 Haemostatix Ltd Haemostatic compositions
GB201508014D0 (en) * 2015-05-11 2015-06-24 Haemostatix Ltd Haemostatic device
US10159720B2 (en) 2015-12-08 2018-12-25 Omrix Biopharmaceuticals Ltd Thrombin microcapsules, preparation and uses thereof
IL242984A0 (en) 2015-12-08 2016-02-29 Omrix Biopharmaceuticals Ltd Thrombin microcapsules, their preparation and how to use them
CN107432955B (zh) * 2016-09-14 2020-09-04 四川蓝光英诺生物科技股份有限公司 用于制备生物构建体的方法和试剂盒
BR112019006932A2 (pt) 2016-10-06 2019-07-02 Matoke Holdings Limited composições antimicrobianas
WO2018065789A1 (en) 2016-10-06 2018-04-12 Matoke Holdings Limited Antimicrobial compositions
JP7431172B2 (ja) 2018-04-23 2024-02-14 ダニスコ・ユーエス・インク ホスホリラーゼ酵素を用いたβ－１，３グリコシド結合を含むグルカンの合成
CN110448719B (zh) * 2019-06-28 2020-05-22 浙江大学 一种促进凝血的丝素-多肽电纺膜及其制备方法
US20230105440A1 (en) * 2021-10-06 2023-04-06 Medtronic, Inc. Anti-thrombogenic coating

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT359653B (de) 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
DE3171072D1 (en) 1981-06-25 1985-07-25 Stroetmann M Serapharm Enriched plasma derivative for promoting wound sealing and wound covering
US5357042A (en) 1984-04-23 1994-10-18 The General Hospital Corporation Synthetic peptides capable of eliciting fibrin-specific monoclonal antibodies lacking fibrinogen-cross-reactivity
US6391343B1 (en) 1991-01-15 2002-05-21 Hemosphere, Inc. Fibrinogen-coated particles for therapeutic use
US5635477A (en) 1991-09-30 1997-06-03 The Dupont Merck Pharmaceutical Company Cyclic compounds useful as inhibitors of platelet glycoprotein IIB/IIIA
IL103252A (en) 1991-09-30 1997-03-18 Du Pont Merck Pharma CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
RU2096415C1 (ru) * 1991-09-30 1997-11-20 Дзе Дюпон Мерк Фармасьютикал Компани Циклические пептиды или их фармацевтически приемлемые соли, фармацевтическая композиция
FI954556A0 (fi) 1993-03-29 1995-09-26 Du Pont Merck Pharma Syklisiä yhdisteitä, jotka ovat käyttökelpoisia verihiutaleen glykoproteiinin IIb/IIIa inhibiittoreina
WO1995029686A1 (en) 1994-05-02 1995-11-09 E.R. Squibb & Sons, Inc. Recombinant fibrin chains, fibrin and fibrin-homologs
AU717906B2 (en) * 1994-12-07 2000-04-06 American National Red Cross, The Supplemented and unsupplemented tissue sealants, methods of their production and use
HUT77369A (hu) 1994-12-16 1998-03-30 Andaris Limited Keresztkötéses mikrorészecskék és felhasználásuk gyógyászati célú hordozóként
JPH11507630A (ja) 1995-06-06 1999-07-06 ヘモスフィアー，インコーポレイテッド 治療および診断用途のためのタンパク質粒子
WO1997044015A1 (en) 1996-05-17 1997-11-27 Andaris Limited Microparticles and their use in wound therapy
ATE284714T1 (de) 1996-10-21 2005-01-15 Quadrant Drug Delivery Ltd Plättchen-ersatzmittel und geeignetes konjugations-herstellungsverfahren
GB9724143D0 (en) 1997-11-14 1998-01-14 Andaris Ltd Pharmaceutical conjugate
DE19849589C1 (de) * 1998-10-27 2000-06-15 Glatt Process Technology Gmbh Fibrin-Gewebekleber-Formulierung und Verfahren zu dessen Herstellung
EP1296724A1 (en) 2000-06-22 2003-04-02 Sam L. Austin Bioadhesive composition and methods of preparation and use
AR032517A1 (es) 2001-01-25 2003-11-12 Nycomed Pharma As Un metodo para preparar una esponja de colageno, un dispositivo para extraer una parte de una espuma de colageno, y una esponja de colageno alargada
CA2473727A1 (en) * 2001-12-04 2003-06-12 Christopher J. Woolverton Storage-stable fibrin sealant
EP1329438B1 (en) * 2002-01-14 2009-04-08 "VLAAMSE INSTELLING VOOR TECHNOLOGISCH ONDERZOEK", afgekort "V.I.T.O." Method for producing metallic and ceramic products
AU2003226265A1 (en) * 2002-04-05 2003-10-27 Baxter Healthcare S.A. Storage stable liquid sealer protein complex
CA2482856A1 (en) 2002-04-15 2003-10-30 American National Red Cross Plasma protein-binding ligands
WO2004045494A2 (en) 2002-11-20 2004-06-03 Bar-Ilan University Biological glue based on thrombin-conjugated nanoparticles
KR101077805B1 (ko) 2003-05-08 2011-10-28 카네카 코포레이션 전혈 처리가 가능한 저밀도 리포 단백 및 피브리노겐의 흡착재, 및 흡착기
AU2004253463B2 (en) 2003-06-16 2010-12-09 Loma Linda University Medical Center Deployable multifunctional hemostatic agent
US7129210B2 (en) * 2003-07-23 2006-10-31 Covalent Medical, Inc. Tissue adhesive sealant
US7927626B2 (en) 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
GB0323378D0 (en) * 2003-10-07 2003-11-05 Univ Leicester Therapeutic agent
CN1544098A (zh) * 2003-11-12 2004-11-10 邹金生 高效神经生长因子生物胶及其制备和使用方法
WO2005076827A2 (en) * 2004-02-04 2005-08-25 Universita' Degli Studi Di Pavia Fbsa compositions for use in promoting fibrinogen aggregation and potentiating fibrin polymerization
US7833978B2 (en) * 2004-02-20 2010-11-16 Emory University Thrombomodulin derivatives and conjugates
US20060034935A1 (en) 2004-07-22 2006-02-16 Pronovost Allan D Compositions and methods for treating excessive bleeding
CN102091347A (zh) 2004-10-20 2011-06-15 伊西康公司 可吸收的止血物
GB0516091D0 (en) * 2005-08-04 2005-09-14 Haemostatix Ltd Therapeutic agent

Also Published As

Publication number Publication date
EP3095468B1 (en) 2021-08-11
IL198699A (en) 2014-12-31
DK2099505T3 (en) 2016-05-30
WO2008065388A2 (en) 2008-06-05
ES2896053T8 (es) 2022-03-03
US9339584B2 (en) 2016-05-17
AU2007327100A1 (en) 2008-06-05
JP2010510818A (ja) 2010-04-08
CN101687061A (zh) 2010-03-31
PL2099505T3 (pl) 2016-08-31
US20160287659A1 (en) 2016-10-06
US20100249044A1 (en) 2010-09-30
US9913876B2 (en) 2018-03-13
RU2503464C2 (ru) 2014-01-10
JP2013188550A (ja) 2013-09-26
EP2099505B1 (en) 2016-02-17
ES2896053T3 (es) 2022-02-23
CA2669738A1 (en) 2008-06-05
ES2570760T3 (es) 2016-05-20
CN101687061B (zh) 2013-03-27
HK1231419A1 (en) 2017-12-22
WO2008065388A3 (en) 2009-11-26
RU2009119257A (ru) 2011-01-10
EP3095468A1 (en) 2016-11-23
IL198699A0 (en) 2010-02-17
AU2007327100B2 (en) 2014-03-06
EP2099505A2 (en) 2009-09-16
CA2669738C (en) 2017-05-30
GB0623607D0 (en) 2007-01-03

Similar Documents

Publication Publication Date Title
US9913876B2 (en) Biogel
AU2012275858B2 (en) Procoagulant peptides and their derivatives and uses therefor
Sierra Fibrin sealant adhesive systems: a review of their chemistry, material properties and clinical applications
JP4954370B2 (ja) 共役不飽和基に対する求核付加反応によって作製される生体適合材料
CN108495658B (zh) 止血材料
JP6717747B2 (ja) フィブリノゲン結合ペプチドを含むペプチドデンドリマー
WO1998057678A2 (en) Compositions containing thrombin and microfibrillar collagen
CN101267843A (zh) 人造血小板
AU2016261108B2 (en) Haemostatic compositions
HK1231419B (en) Biogel

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101126

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20101126

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111104

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121220

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130319

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130327

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130419

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130426

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130517

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130524

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130619

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130807

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20131106

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20131113

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20131202

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20131209

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140107

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20140130

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140530

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20140530

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20140623

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20140711

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20150105

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150828

R150 Certificate of patent or registration of utility model

Ref document number: 5801994

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250